Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

A rating scale for depression

Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · see citing works

Research Diagnostic Criteria

Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946 · see citing works

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.

Brady, L. S., Whitfield, H. J., Fox, R. J., Gold, P. W., & Herkenham, M. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115086 · Cited by 338 · see citing works

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

Bánki, C. M., Bissette, G., Arató, M., O'Connor, L., & Nemeroff, C. B. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.7.873 · Cited by 336 · see citing works

Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy

Nemeroff, C. B., Bissette, G., Akil, H., & Fink, M. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.1.59 · Cited by 253 · see citing works

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

Brady, L. S., Gold, P. W., Herkenham, M. A., Lynn, A. B., & Whitfield, H. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)90459-m · Cited by 236 · see citing works

Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia-nervosa

Gold, P. W., Kaye, W., Robertson, G. L., & Ebert, M. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305123081902 · Cited by 192 · see citing works

Abnormalities in the Regulation of Vasopressin and Corticotropin Releasing Factor Secretion in Obsessive-Compulsive Disorder

Altemus, M. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 186 · see citing works

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

Kling, M. A., Roy, A., Doran, R. J., Calabrese, J. R., Rubinow, D. R., DAVID, H. J., May, C., Post, R. M., Chrousos, G. P., & Gold, P. W. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-260 · Cited by 145 · see citing works

The effects of separate or combined infusions of corticotrophin-releasing factor and vasopressin either intraventricularly or into the amygdala on aggressive and investigative behaviour in the rat

El-Kabir, D. R., Wyatt, M. E., Vellucci, S. V., & Herbert, J. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90018-r · Cited by 102 · see citing works

Cerebrospinal Fluid Vasopressin—Changes in Depression

Gjerris, A., Vendsborg, P. B., HAMMER, M., Christensen, N. J., & Rafaelsen, O. J. (1985) · The British Journal of Psychiatry · doi:10.1192/bjp.147.6.696 · Cited by 69 · see citing works

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

Heim, C., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01157-x · Cited by 2,791 · see citing works

The Corticosteroid Receptor Hypothesis of Depression

Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · see citing works

Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety

Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,488 · see citing works

The stress system in the human brain in depression and neurodegeneration

Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · see citing works

Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation

HOLSBOER, F., & Barden, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 851 · see citing works

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767 · see citing works

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

Holsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · see citing works

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders.

Coplan, J. D., Andrews, M. W., Rosenblum, L. A., Owens, M. J., Friedman, S., Gorman, J. M., & Nemeroff, C. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1619 · Cited by 649 · see citing works

Depression in Patients With Cancer

McDaniel, J. S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950140007002 · Cited by 541 · see citing works

Long term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring

Plotsky, P. M., Thrivikraman, K. V., Nemeroff, C. B., Caldji, C., Sharma, S., & Meaney, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300769 · Cited by 522 · see citing works

Effects of early adverse experiences on brain structure and function: clinical implications

Kaufman, J., Plotsky, P. M., Nemeroff, C. B., & Charney, D. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00998-7 · Cited by 508 · see citing works

Brain structures in pediatric maltreatment-related posttraumatic stress disorder: a sociodemographically matched study

De Bellis, M. D., Keshavan, M. S., Shifflett, H., Iyengar, S., Beers, S. R., Hall, J., & Moritz, G. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01459-2 · Cited by 632 · see citing works

The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders

Heim, C., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00224-3 · Cited by 502 · see citing works

Stress Hormone Regulation: Biological Role and Translation into Therapy

Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473 · see citing works

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression

Purba, J. S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020055007 · Cited by 433 · see citing works

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

Habib, K. E., Weld, K. P., Rice, K. C., Pushkas, J., Champoux, M., Listwak, S. J., WEBSTER, E. L., Atkinson, A. J., Schulkin, J. A., Contoreggi, C. S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6079 · Cited by 404 · see citing works

Cerebrospinal Fluid Vasopressin Levels

Coccaro, E. F., Kavoussi, R. J., Hauger, R. L., Cooper, T. B., & Ferris, C. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.8.708 · Cited by 392 · see citing works

The CRF system, stress, depression and anxiety—insights from human genetic studies

Binder, E. B., & Nemeroff, C. B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.141 · Cited by 379 · see citing works

Hypercortisolemia and depression

Gillespie, C. F., & Nemeroff, C. B. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000163456.22154.d2 · Cited by 361 · see citing works

Understanding the relation between obesity and depression: Causal mechanisms and implications for treatment.

Markowitz, S. M., Friedman, M. A., & Arent, S. M. (2008) · Clinical Psychology Science and Practice · doi:10.1111/j.1468-2850.2008.00106.x · Cited by 339 · see citing works

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders

Anisman, H., Merali, Z., & Hayley, S. P. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 334 · see citing works

Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA3 pyramidal neurons after chronic stress

Magariños, A. M., Deslandes, A., & McEwen, B. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00163-6 · Cited by 330 · see citing works

The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans

Wichers, M., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003103 · Cited by 329 · see citing works

Plasma Levels of Arginine Vasopressin Elevated in Patients with Major Depression

van Londen, L. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00054-7 · Cited by 306 · see citing works

Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: Implications for the pathophysiology of depression

Scott, L. V., & Dinan, T. G. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00027-7 · Cited by 281 · see citing works

Pituitary volumes in pediatric maltreatment-related posttraumatic stress disorder

Thomas, L. A., & Bellis, M. D. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.021 · Cited by 267 · see citing works

The Corticotropin-Releasing Factor Family: Physiology of the Stress Response

Deussing, J. M., & Chen, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2017 · Cited by 259 · see citing works

Early-life stress and HPA axis trigger recurrent adulthood depression.

Juruena, M. F. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.10.020 · Cited by 232 · see citing works

Region-specific roles of the corticotropin-releasing factor–urocortin system in stress

Henckens, M. J. A. G., Deussing, J. M., & Chen, A. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.94 · Cited by 245 · see citing works

Stress sensitivity and the development of affective disorders

Bale, T. L. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.033 · Cited by 245 · see citing works

The Neurobiological Toll of Child Abuse and Neglect

Neigh, G. N., Gillespie, C. F., & Nemeroff, C. B. (2009) · Trauma Violence & Abuse · doi:10.1177/1524838009339758 · Cited by 240 · see citing works

Early life adversity and the epigenetic programming of hypothalamic-pituitary-adrenal function

Anacker, C., O'Donnell, K. J., & Meaney, M. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.3/canacker · Cited by 237 · see citing works

CRF1receptor signaling pathways are involved in stress‐related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome

Taché, Y., Martı́nez, V., Wang, L., & Million, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705760 · Cited by 228 · see citing works

Effects of Antidepressant Drugs on the Behavioral and Physiological Responses to Lipopolysaccharide (LPS) in Rodents

Yirmiya, R. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00226-8 · Cited by 224 · see citing works

Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects

Carpenter, L. L., Tyrka, A. R., McDougle, C. J., Malison, R. T., Owens, M. J., Nemeroff, C. B., & Price, L. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300375 · Cited by 209 · see citing works

Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?

Post, A., & Keck, M. E. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00023-1 · Cited by 209 · see citing works

Corticotropin-releasing hormone in depression and post-traumatic stress disorder

Kasckow, J. W., Baker, D. G., & Geracioti, T. D. (2001) · Peptides · doi:10.1016/s0196-9781(01)00399-0 · Cited by 203 · see citing works

Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: Focus on vasopressin and glyoxalase-I

Landgraf, R., Kessler, M. S., Bunck, M., Murgatroyd, C., Spengler, D., Zimbelmann, M., Nußbaumer, M., Czibere, L., Turck, C. W., Singewald, N., et al. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.003 · Cited by 199 · see citing works

Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders

Keck, M. E., & Holsboer, F. (2001) · Peptides · doi:10.1016/s0196-9781(01)00398-9 · Cited by 198 · see citing works

Sex differences in stress responses: a critical role for corticotropin-releasing factor

Bangasser, D. A., & Wiersielis, K. (2018) · HORMONES · doi:10.1007/s42000-018-0002-z · Cited by 193 · see citing works

Neurobiological effects of childhood abuse: implications for the pathophysiology of depression and anxiety

Penza, K. M., Heim, C. C., & Nemeroff, C. B. (2003) · Archives of Women s Mental Health · doi:10.1007/s00737-002-0159-x · Cited by 183 · see citing works

The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response

Dedic, N., Chen, A., & Deussing, J. M. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 181 · see citing works

O eixo hipotálamo-pituitária-adrenal, a função dos receptores de glicocorticóides e sua importância na depressão

Juruena, M. F., Cleare, A. J., & Pariante, C. M. (2004) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462004000300009 · Cited by 181 · see citing works

Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis

Mello, A. F., Mello, M. F., Carpenter, L. L., & Price, L. H. (2003) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462003000400010 · Cited by 169 · see citing works

Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men

Austin, M. C., Janosky, J. E., & Murphy, H. A. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001250 · Cited by 162 · see citing works

Sex differences in vasopressin and oxytocin innervation of the brain

DEVRIES, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00402-0 · Cited by 169 · see citing works

Assessment and treatment of depression in the cancer patient

Newport, D. J., & Nemeroff, C. B. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00011-7 · Cited by 167 · see citing works

Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model

Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., & Landgraf, R. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300040 · Cited by 168 · see citing works

Neuroendocrinological mechanisms of actions of antidepressant drugs

Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167 · see citing works

Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats Implications for Pathogenesis of Affective Disorders

Keck, M. E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00351-7 · Cited by 167 · see citing works

Biologic findings of post-traumatic stress disorder and child maltreatment

Bellis, M. D. D., & Thomas, L. A. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0027-z · Cited by 164 · see citing works

Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain

Keck, M. E., Sillaber, I., Ebner, K., Welt, T., Toschi, N., Kaehler, S. T., Singewald, N., Philippu, A., Elbel, G. K., Wotjak, C. T., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00243.x · Cited by 164 · see citing works

Sex Differences in Molecular and Cellular Substrates of Stress

Bangasser, D. A., & Valentino, R. J. (2012) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-012-9824-4 · Cited by 160 · see citing works

Glucocorticoids and depression

Steckler, T., Holsboer, F., & Reul, J. M. H. M. (1999) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.1999.0046 · Cited by 160 · see citing works

Corticotropin-Releasing Hormone, Arginine Vasopressin, Gastrin-Releasing Peptide, and Neuromedin B Alterations in Stress-Relevant Brain Regions of Suicides and Control Subjects

Merali, Z., Kent, P., Du, L., Hrdina, P. D., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., & Anisman, H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.008 · Cited by 155 · see citing works

Depression and Endocrine Disorders: Focus on the Thyroid and Adrenal System

Musselman, D. L., & Nemeroff, C. B. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298504 · Cited by 156 · see citing works

Innovative Approaches for the Treatment of Depression: Targeting the HPA Axis

THOMSON, F. J., & Craighead, M. W. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9518-3 · Cited by 155 · see citing works

Neurobiology of resilience in depression: immune and vascular insights from human and animal studies

Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 156 · see citing works

Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus

Harro, J., & Oreland, L. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00082-0 · Cited by 149 · see citing works

Hypothalamic‐Pituitary‐Adrenocortical Axis: Neuropsychiatric Aspects

Jacobson, L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130036 · Cited by 152 · see citing works

The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development

Ring, R. H. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 141 · see citing works

Neuroendocrine and Behavioral Effects of Repetitive Transcranial Magnetic Stimulation in a Psychopathological Animal Model Are Suggestive of Antidepressant-like Effects

Keck, M. E. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00191-3 · Cited by 137 · see citing works

Elevated Concentrations of CRF in the Locus Coeruleus of Depressed Subjects

Bissette, G., Klimek, V., Pan, J., Stockmeier, C., & Ordway, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300191 · Cited by 136 · see citing works

Selective serotonin reuptake inhibitor treatment of early postnatal mice reverses their prenatal stress-induced brain dysfunction

Ishiwata, H., Shiga, T., & Okado, N. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.048 · Cited by 133 · see citing works

Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety

Takahashi, L. K., Ho, S. P., Livanov, V., Graciani, N., & Arneric, S. P. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02405-2 · Cited by 132 · see citing works

Brain-immune interactions and disease susceptibility

Marques-Deak, A., Cizza, G., & Sternberg, E. M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001643 · Cited by 132 · see citing works

Diet, Obesity, and Depression: A Systematic Review

Patsalos, O., Keeler, J. L., Schmidt, U. H., Penninx, B. W. J. H., Young, A. H., & Himmerich, H. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030176 · Cited by 127 · see citing works

The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence

Bruijnzeel, A. W., & Gold, M. S. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.01.007 · Cited by 125 · see citing works

Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients

Carpenter, L. L., Moreno, F. A., Kling, M. A., Anderson, G. M., Regenold, W. T., Labiner, D. M., & Price, L. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.025 · Cited by 123 · see citing works

Sensitivity to stress: Dysregulation of CRF pathways and disease development

Bale, T. L. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.01.009 · Cited by 122 · see citing works

Involvement of the Endocannabinoid System in the Ability of Long-Term Tricyclic Antidepressant Treatment to Suppress Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis

Hill, M. N., Ho, W. ‐. V., Sinopoli, K. J., Viau, V., Hillard, C. J., & Gorzalka, B. B. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301092 · Cited by 116 · see citing works

Corticosteroid receptor-gene variants: modulators of the stress-response and implications for mental health

DeRijk, R. H., van Leeuwen, N., Klok, M. D., & Zitman, F. G. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.012 · Cited by 117 · see citing works

Association of Polymorphisms in Genes Regulating the Corticotropin-Releasing Factor System With Antidepressant Treatment Response

Binder, E. B., Owens, M. J., Liu, W., Deveau, T. C., Rush, A. J., Trivedi, M. H., D, M. F. M., Bradley, B., Ressler, K. J., & Nemeroff, C. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.18 · Cited by 111 · see citing works

Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response

Nikisch, G., Mathé, A. A., Czernik, A., Thiele, J., Bohner, J., Eap, C. B., Ågren, H., & Baumann, P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0034-3 · Cited by 107 · see citing works

Sex differences in stress-related receptors: ″micro″ differences with ″macro″ implications for mood and anxiety disorders

Bangasser, D. A. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-2 · Cited by 108 · see citing works

Antagonism of CRF Receptors Prevents the Deficit in Brain Reward Function Associated with Precipitated Nicotine Withdrawal in Rats

Bruijnzeel, A. W., Zislis, G., Wilson, C., & Gold, M. S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301192 · Cited by 106 · see citing works

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression

Geracioti, T. D., Loosen, P. T., & Orth, D. N. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00312-5 · Cited by 105 · see citing works

Links Between Depression and Substance Abuse in Adolescents

Rao, U. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.002 · Cited by 104 · see citing works

The impact of treatment on HPA axis activity in unipolar major depression

McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103 · see citing works

The effect of increased serotonergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies

Carrillo, M., Ricci, L. A., Coppersmith, G., & Melloni, R. H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1543-2 · Cited by 103 · see citing works

Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?

Kokras, N., Hodes, G. E., Bangasser, D. A., & Dalla, C. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14710 · Cited by 94 · see citing works

Chronic Stress and Individual Vulnerability

Schmidt, M. V., Sterlemann, V., & Müller, M. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1410.017 · Cited by 99 · see citing works

Evidence for the role of corticotropin-releasing factor in major depressive disorder

Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93 · see citing works

Corticotropin-releasing factor-related peptides, serotonergic systems, and emotional behavior

Fox, J. H., & Lowry, C. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00169 · Cited by 93 · see citing works

Separation anxiety in dogs: What progress has been made in our understanding of the most common behavioral problems in dogs?

Ogata, N. (2016) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2016.02.005 · Cited by 93 · see citing works

Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety

Keck, M. E. (2006) · Amino Acids · doi:10.1007/s00726-006-0333-y · Cited by 92 · see citing works

Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects

Fossey, M. D., Lydiard, R. B., Ballenger, J. C., Laraia, M. T., Bissette, G., & Nemeroff, C. B. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00197-2 · Cited by 90 · see citing works

Corticotropin-releasing hormone and the hypothalamic–pituitary–adrenal axis in psychiatric disease

Naughton, M., Dinan, T. G., & Scott, L. V. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59602-4.00005-8 · Cited by 90 · see citing works

Elevated Midpregnancy Corticotropin-Releasing Hormone Is Associated with Prenatal, But Not Postpartum, Maternal Depression

Rich-Edwards, J. W., Mohllajee, A. P., KLEINMAN, K. P., Hacker, M. R., Majzoub, J. A., Wright, R. J., & Gillman, M. W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2535 · Cited by 88 · see citing works

Two-Week Treatment With the Selective Serotonin Reuptake Inhibitor Citalopram Reduces Contextual Anxiety but Not Cued Fear in Healthy Volunteers: A Fear-Potentiated Startle Study

Grillon, C., Chavis, C., Covington, M. F., & Pine, D. S. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.141 · Cited by 88 · see citing works

Childhood adversity and allostatic overload of the hypothalamic–pituitary–adrenal axis: A vulnerability model for depressive disorders

Wilkinson, P. O., & Goodyer, I. M. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000472 · Cited by 86 · see citing works

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

Altemus, M. M. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100042004 · Cited by 86 · see citing works

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

Griebel, G., Stemmelin, J., Gal, C. S., & Soubrié, P. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764797 · Cited by 84 · see citing works

The pharmacological properties of antidepressants

Racagni, G., & Popoli, M. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283311acd · Cited by 83 · see citing works

The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats

Jutkiewicz, E. M., Wood, S. K., Houshyar, H., Hsin, L., Rice, K. C., & Woods, J. H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2164-z · Cited by 83 · see citing works

Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression

Swaab, D. F., Fliers, E., Hoogendijk, W. J. G., Veltman, D. J., & Zhou, J. (2000) · Progress in brain research · doi:10.1016/s0079-6123(00)26025-1 · Cited by 81 · see citing works

The Vasopressin V_1bReceptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81 · see citing works

An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP

CONNAN, F., LIGHTMAN, S., LANDAU, S., WHEELER, M., TREASURE, J., & CAMPBELL, I. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.12.005 · Cited by 80 · see citing works

Hypothalamic-pituitary-adrenocortical activity and response to cognitive behavior therapy in unmedicated, hospitalized depressed patients

Thase, M. E., Dubé, S., Bowler, K., Howland, R. H., Myers, J. E., Friedman, E. S., & Jarrett, D. B. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.7.886 · Cited by 80 · see citing works

Interaction of Stress, Corticotropin-Releasing Factor, Arginine Vasopressin and Behaviour

Beurel, E., & Nemeroff, C. B. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_306 · Cited by 64 · see citing works

Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression

Poretti, M. B., Sawant, R. S., Rask‐Andersen, M., de Cúneo, M. F., Schiöth, H. B., Pérez, M. F., & Carlini, V. P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4187-4 · Cited by 22 · see citing works

Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers

Bellis, M. D. D., Geracioti, T. D., Altemus, M. M., & Kling, M. A. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90103-k · Cited by 66 · see citing works

Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive Disorder

Meltzer, H. Y. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00280-1 · Cited by 76 · see citing works

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram

Nikisch, G., Ågren, H., Eap, C. B., Czernik, A., Baumann, P., & Mathé, A. A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005158 · Cited by 98 · see citing works

Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro

Altemus, M. M., Cizza, G., & Gold, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)91326-a · Cited by 60 · see citing works